Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04666077 · ClinicalTrials.gov registry record · NA
Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
A NA study of Mild Cognitive Impairment and Alzheimers Disease, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT04666077 is a NA study of Mild Cognitive Impairment and Alzheimers Disease that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 100 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04666077, a NA study of Mild Cognitive Impairment and Alzheimers Disease, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study compares different music therapy (MT) experiences and their impact on memory and language in patients with Alzheimer's disease and Mild Cognitive Impairment. The 12-month study will assess the role of common experiences involving familiar music and other pleasant events (blinded control) to benefit cognition and measure the quality of life for people with Alzheimer's disease and Mild Cognitive Impairment. Following screening, all participants will meet with a licensed music therapist at the first study visit. Thereafter, each group will have an individualized schedule of follow-up telephone calls and visits. Screening for the study and participation in the study intervention can be completed in-person or from your home, if you do not live in the area.
Conditions Studied
Interventions
- BEHAVIORAL Home-based MT through Supervised, Supported Singing (H3S)
- BEHAVIORAL Individualized Music Therapy (IMT)
- OTHER Attention Control (AtCon)
Study Locations (2)
New York
- Louis Armstrong Center for Music and Medicine, Mount Sinai Beth Israel - New York
- Alzheimer's Disease Research Center, Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-08-27 |
| Est. Completion | 2025-07-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04666077
The ClinicalTrials.gov registry entry for NCT04666077 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (92% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 3 interventions - of which Home-based MT through Supervised, Supported Singing (H3S) is the first listed.
NCT04666077 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04666077 about?
NCT04666077 is a clinical study titled "Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)". This study compares different music therapy (MT) experiences and their impact on memory and language in patients with Alzheimer's disease and Mild Cognitive Impairment. The 12-month study will assess the role of common experiences involving familiar music and other pleasant events (blinded control)...
What is the current status of trial NCT04666077?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2019-08-27. Estimated completion is 2025-07-25.
What conditions does trial NCT04666077 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment, Alzheimers Disease.
What interventions are being tested in trial NCT04666077?
The interventions under investigation include: Home-based MT through Supervised, Supported Singing (H3S) (BEHAVIORAL), Individualized Music Therapy (IMT) (BEHAVIORAL), Attention Control (AtCon) (OTHER).
Who is sponsoring clinical trial NCT04666077?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04666077 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Impact of Intensive Computerized Cognitive Training
RECRUITING · NA
-
Multimodal Investigation of Neural Plasticity
RECRUITING · NA
-
GAMES Intervention in MCI (Mild Cognitive Impairment)
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.